State Street Corp Amryt Pharma PLC Transaction History

State Street Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.0 - $14.77 $595 - $1,255	-85 Reduced 0.44%	19,376 $282,000
Q4 2022 Feb 14, 2023	BUY	$6.68 - $7.58 $607 - $689	91 Added 0.47%	19,461 $142,000
Q3 2022 Nov 15, 2022	BUY	$6.8 - $8.01 $131,716 - $155,153	19,370 New	19,370 $134,000
Q4 2021 Feb 14, 2022	SELL	$9.44 - $12.24 $102,471 - $132,865	-10,855 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $104,533 - $135,361	10,855 New	10,855 $131,000

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.